Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-30

Clinical Trial Update: A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether acyclovir can prevent HIV infection in people with genital herpes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACYCLOVIR (Acyclovir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, HIV Seronegativity | Phase 3 | Status: COMPLETED